The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

The U.S. Food and Drug Administration approved the Wegovy pill in late December 2025 for adults who are obese or overweight ...

According to PR Newswire, Novo Nordisk said the pill is also approved to help reduce the risk of major cardiovascular events, ...

THE price of a daily pill version of the fat jab Wegovy has gone on sale for the first time today (January 5) has been ...

Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are ...

The Wegovy pill is now available in the starting dose at pharmacies and telehealth platforms nationally, opening a new phase ...

The lowest doses of the daily pill will cost $149 a month for people paying out of pocket, offering a cheaper alternative to ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

Denmark's Novo Nordisk will offer its 1.5 and 4 milligram Wegovy weight loss pills at $149 per month to self-paying patients ...